Temporary Transvenous Pacing Is Required When Acute Bradycardia or Heart Block Threatens Cardiac Output.

The Scene

The call comes from the emergency department at 2:14 AM. A 72-year-old man from Rantoul, Illinois, drove himself to the hospital because he felt dizzy during dinner and then nearly passed out in the driveway. His wife is in the waiting room. He is awake, pale, and his pulse is 32 beats per minute. The ECG prints before he has been in the room three minutes: third-degree atrioventricular block. The P waves march across the strip at their own tempo, 82 per minute. The QRS complexes plod along at 29 per minute, independent of every P wave, originating somewhere in the ventricles because the conduction system has stopped relaying the atrial signal. The atria and the ventricles are no longer talking to each other.

His blood pressure is 78/54 mmHg. He is perfusing, barely.

The emergency physician calls cardiology. While the attending is in transit, the nursing staff places the external pacing pads from the Zoll M Series on his chest and back in the anterior-posterior position. The pacemaker output is set to 80 milliamperes and the rate to 60 beats per minute. Capture is confirmed on the monitor: each pacing spike is followed by a wide QRS complex, and his blood pressure climbs to 96/62. He is grimacing with every beat. The diaphragm contracts in sync with each shock. The intern draws up two milligrams of morphine and a milligram of midazolam. It helps, but not enough. External pacing was never designed to be tolerable for more than an hour.

That distinction matters. The transcutaneous pacemaker is a bridge. It buys time for the definitive intervention: a transvenous pacing catheter advanced through a central vein into the right ventricle, where low-energy electrical pulses delivered directly to the endocardium can maintain cardiac output without the pain of transcutaneous stimulation and without the unreliability of surface electrodes working through chest wall, ribs, and lung.

The cardiologist arrives fourteen minutes after the call. She has done this procedure more times than she can count, in this hospital and before that at University of Illinois in Chicago. The equipment is already at the bedside. She asks the nurse to open the fluoroscopy suite; if the patient is stable enough, she would rather place the lead under X-ray guidance where she can see the catheter tip in real time. But tonight, the patient’s pressure is tenuous, and waiting for a fluoroscopy technician to arrive at 2 AM is time she does not have. She will use the balloon-flotation technique at the bedside, relying on the ECG to confirm positioning.

This is temporary transvenous pacing. It is one of the most time-sensitive procedures in cardiology. When it is done well, in the right patient, at the right moment, it is life-saving. When the indication is uncertain or the setup is improvised, it carries serious risk: pneumothorax, cardiac perforation, infection, lead displacement. The cardiologist who manages this procedure must understand both the mechanics of pacing and the biology of the condition that made pacing necessary.

What It Is

Temporary transvenous pacing (TTP) is a procedure in which an electrode catheter is introduced through a large central vein, advanced into the right ventricle, and connected to an external pulse generator that delivers low-energy electrical stimuli directly to the endocardium. The purpose is to maintain an adequate heart rate when the patient’s intrinsic rhythm is too slow, absent, or unreliable to sustain cardiac output.

The word “temporary” is precise. Unlike a permanent pacemaker, which is implanted subcutaneously with a battery expected to last 8 to 15 years, a temporary transvenous pacing system sits outside the body. The pulse generator rests on the bed or the bedside pole. The catheter traverses the skin at the venous access site and enters the right ventricle through an introducer sheath that exits the skin. This configuration is inherently unstable. The lead can migrate. The entry site can become infected. The generator battery can drain. Temporary transvenous pacing is a bridge procedure: it sustains rhythm until the underlying cause resolves, until a permanent pacemaker can be implanted, or until the patient can be stabilized for surgical intervention.

The FDA classifies pacing catheters used for temporary transvenous pacing as Class II devices, cleared through the 510(k) pathway, on the basis of substantial equivalence to predicate devices. Balloon-tipped flotation pacing catheters such as the Arrow Berman Angiographic Catheter and similar products from Edwards Lifesciences and Medline Industries are among the commonly used options. The external pulse generators are separately classified Class III devices in some configurations; the Medtronic 5392 Dual Chamber Temporary Pacemaker and the Osypka PACE203 are representative products in widespread institutional use. FDA 510(k) clearance applies to the combination of catheter, introducer, and generator as distinct regulatory units.

Temporary transvenous pacing is distinct from two related procedures:

• Transcutaneous (external) pacing delivers high-energy pulses through the skin via adhesive pads and does not require vascular access. It is fast to initiate but painful and unreliable for sustained use.
• Permanent pacemaker implantation requires a skin incision, a subcutaneous pocket for the generator, and fluoroscopic lead positioning with active fixation; it is not a bedside emergency procedure.

Temporary transvenous pacing occupies the critical middle ground: more reliable than transcutaneous and more rapidly deployable than permanent implantation.

The Mechanism

3.1 Normal Cardiac Conduction

The heart’s pacemaker is the sinoatrial (SA) node, a cluster of specialized cells in the high right atrium. At rest, the SA node fires 60 to 100 times per minute, generating an action potential that propagates across both atria, reaches the atrioventricular (AV) node, pauses (to allow atrial emptying into the ventricles), then travels down the Bundle of His, splits into the left and right bundle branches, and fans out through the Purkinje fibers to activate the ventricles in a coordinated, muscular squeeze. The result is a normal P-QRS-T pattern on the ECG and a cardiac output of approximately 5 liters per minute at rest.

3.2 The Biology of Conduction Failure

When the SA node fires but the AV node fails to transmit, the result is AV block. Three degrees of severity exist:

• First-degree AV block: the PR interval is prolonged (greater than 200 milliseconds) but every P wave conducts. This is a conduction delay, not a block, and does not require pacing.
• Second-degree AV block: some P waves fail to conduct. Mobitz Type I (Wenckebach) involves progressive PR lengthening until a P wave is dropped; it is usually benign, originating in the AV node, and rarely requires pacing. Mobitz Type II involves sudden non-conduction without PR prolongation and is more ominous because it often originates below the AV node in the His-Purkinje system, where it can progress without warning to complete heart block.
• Third-degree (complete) AV block: no atrial impulses reach the ventricles. The ventricles are driven by a junctional or ventricular escape rhythm, typically 30 to 45 beats per minute. At that rate, cardiac output is severely reduced; syncope, hypotension, and death are the consequences if the escape rhythm fails or if the patient’s demands exceed what 30-45 beats per minute can supply.

Complete heart block can result from inferior myocardial infarction (right coronary artery supplying the AV node in approximately 90% of people), from anterior MI (bilateral bundle branch block), from cardiac surgery, from Lyme disease myocarditis, from sarcoidosis, from degenerative disease of the conduction system (Lev-Lenegre disease), and from drug toxicity (beta-blockers, calcium channel blockers, digoxin, amiodarone).

3.3 How the Pacing Catheter Works

The pacing catheter delivers a brief (typically 1 to 2 milliseconds) electrical pulse at a set voltage (measured in milliamps or volts, depending on the generator) to the right ventricular endocardium. The pulse depolarizes myocardial cells adjacent to the electrode tip, initiating an action potential that propagates across the ventricle via the same Purkinje network the normal conduction system uses. The result is a wide QRS complex (because conduction is not traveling through the specialized His-Purkinje fast-pathway system in its normal sequence) and a ventricular contraction.

The key parameters are:

• Pacing rate: set above the intrinsic escape rate. In complete heart block, setting the rate at 60 beats per minute ensures the external pacemaker drives the ventricle whenever the intrinsic rate falls below 60.
• Output (milliamps or volts): the energy delivered per pulse. The minimum output required to reliably capture the ventricle is the pacing threshold; standard practice sets the output at two to three times the pacing threshold to ensure a safety margin.
• Sensitivity (millivolts): the amplitude of native electrical activity that the generator will detect and use to inhibit its own pacing spike (demand mode). A sensitivity set at 2 mV means the generator will suppress pacing if it detects a native QRS of at least 2 mV, avoiding competitive pacing with the patient’s own rhythm.

3.4 Failure to Pace and Failure to Sense

Two categories of device malfunction matter clinically:

• Failure to capture: the pacing spike appears on the ECG but is not followed by a QRS complex. The most common causes are lead displacement, raised pacing threshold (often from electrolyte abnormalities or myocardial edema at the electrode tip), or lead perforation. Management: increase output, reposition the lead, correct electrolytes.
• Failure to sense: the generator delivers pacing spikes even when native QRS complexes are present, risking delivery of a stimulus during the vulnerable period of ventricular repolarization (the T wave) and potentially triggering ventricular fibrillation. Management: increase sensitivity (lower the millivolt threshold), recheck lead position and connection.

How It Is Used

4.1 Indications

The indications for temporary transvenous pacing are hemodynamic or electrical instability from bradycardia that is unlikely to resolve spontaneously within minutes. The major categories:

1. Complete (third-degree) AV block with hemodynamic compromise
2. Symptomatic Mobitz Type II second-degree AV block (significant risk of progression to complete heart block)
3. High-degree AV block complicating acute myocardial infarction (inferior MI with third-degree block affecting the AV node is often transient and may resolve within days; anterior MI with bilateral bundle branch block is more ominous)
4. Sinus node dysfunction with hemodynamically significant bradycardia unresponsive to atropine
5. Bridge to permanent pacemaker implantation in a patient who cannot wait (active infection precluding immediate permanent implant, or hemodynamic instability requiring stabilization first)
6. Overdrive pacing to suppress torsades de pointes until the QT-prolonging cause is corrected
7. Post-cardiac surgery complete heart block that may resolve as surgical edema resolves (common after AVR for calcific aortic stenosis or after complex congenital heart surgery)

Atropine (0.5 to 1.0 mg IV) should be attempted first in vagally mediated bradycardias and in inferior MI with AV block, given the high likelihood of AV nodal rather than infranodal block in that setting. Transcutaneous pacing is initiated simultaneously to provide immediate rate support while the transvenous approach is prepared.

4.2 Vascular Access Selection

Three central venous access routes are used:

• Right internal jugular vein: the most direct path to the right ventricle, with the catheter advancing roughly in a straight line into the superior vena cava and then into the right heart. Preferred at many centers for its predictable anatomy and low pneumothorax risk.
• Left subclavian vein: allows comfortable catheter stability due to the natural curve leading the tip to the right ventricular apex. Higher pneumothorax risk than internal jugular.
• Right femoral vein: fastest to access, particularly when the patient cannot be positioned for neck access. Greater infection risk over time due to groin location. The catheter must travel a longer course through the inferior vena cava, increasing displacement risk.

The access site chosen depends on operator experience, urgency, and available equipment. Ultrasound guidance for venous access reduces complications and is now the standard of care at most academic and tertiary-care centers 5 / Solid .

A 6 French or 7 French introducer sheath is placed over a guidewire by the Seldinger technique. The pacing catheter passes through the sheath.

4.3 The Balloon-Flotation Technique (Bedside, Without Fluoroscopy)

The balloon-tipped pacing catheter (such as the Arrow 5 French balloon-flotation pacing catheter) has a small balloon at its tip. With the balloon inflated to approximately 1.5 mL, venous blood flow carries the catheter from the right atrium through the tricuspid valve into the right ventricle, where the balloon deflates and the tip settles at the apex. The clinician watches for the following ECG changes to confirm position:

• Right atrial position: low-amplitude, near-isoelectric tracing
• Right ventricular entry: marked negative deflection (unipolar “injury current” pattern with deep ST elevation in the pacing channel, indicating electrode contact with ventricular endocardium)

The generator output is set to 1.5 to 2 times the threshold and pacing is confirmed by observing a paced QRS followed by mechanical capture (pulse on palpation or blood pressure response).

The bedside balloon-flotation technique is faster but less reliable than fluoroscopy-guided placement. Published rates of failure to achieve stable right ventricular position without fluoroscopy range from 15% to 30% 4 / Promising . In a hemodynamically unstable patient at 2 AM in a community hospital, it is frequently the only option.

4.4 Fluoroscopy-Guided Placement

In a patient who is hemodynamically stable enough to wait, or in whom balloon flotation has failed, fluoroscopy in the cardiac catheterization laboratory or an equipped emergency department provides direct visualization of catheter position. The lead tip should be placed at the right ventricular apex or septum, angled slightly anteriorly. The operator checks for lead stability with deep inspiration and cough. Active-fixation catheters (with a small helix at the tip that screws into the septum) provide superior stability compared to passive-fixation catheters, particularly in patients who must be mobilized.

4.5 Settings After Placement

Following confirmed capture:

• Rate: set at 10 to 20 beats per minute above the intrinsic rate, typically 60 per minute as a baseline
• Output: set at 2 to 3 times pacing threshold
• Sensitivity: set to 1 to 2 mV (demand mode) to inhibit pacing when a native QRS appears

Daily threshold checks are performed to detect lead maturation (threshold typically rises over days as local myocardial edema increases at the electrode-tissue interface).

The Evidence

The evidence base for temporary transvenous pacing is largely observational and procedural; no randomized controlled trial has compared TTP to no pacing in complete heart block with hemodynamic compromise, because withholding pacing in that setting would be ethically indefensible. What the literature addresses is technique, access route, and complication rates.

5.1 Complication Rates

A systematic review of temporary transvenous pacing complications compiled data across 14 studies encompassing 1,380 patients 4 / Promising . Overall complication rate ranged from 14% to 40% across studies, depending on operator experience, access site, and duration of pacing. Major complications included:

Lead displacement is the most common failure mode and underscores the importance of daily threshold testing and secure sheath fixation. Perforation risk is higher with stiff catheters; the balloon-flotation design substantially reduces this risk.

5.2 Duration and Infection Risk

Infection risk increases substantially after 72 hours of temporary transvenous pacing 5 / Solid . Most infectious complications are at the entry site; endovascular infection (catheter-related bloodstream infection) is less common but life-threatening in a population already hemodynamically compromised. The practical implication: if pacing will be needed for more than 72 hours and the underlying cause is not expected to resolve, the decision between continuing temporary pacing and moving to permanent implantation should be made explicitly before the 72-hour mark.

5.3 AV Block in Inferior MI: The Resolution Rate

In the specific context of inferior ST-elevation MI complicated by complete heart block, the prognosis for conduction recovery is substantially better than in other etiologies. Inferior MI produces AV nodal ischemia (the AV nodal artery arises from the right coronary artery in 90% of anatomy), and the block is typically at the level of the AV node itself, with a junctional escape rhythm at 40-60 beats per minute. With successful revascularization, AV nodal function typically recovers within 3 to 7 days 5 / Solid 90143-7). Prophylactic temporary pacing is reasonable in this setting as a bridge; permanent pacing is rarely required.

Anterior MI with bilateral bundle branch block (complete LBBB or RBBB with fascicular block) carries a worse prognosis for conduction recovery and a higher risk of progression to complete heart block 5 / Solid . Temporary pacing is a more reliable bridge to permanent pacing in this group.

5.4 Atropine Response as a Predictor

A complete response to atropine (heart rate increase to greater than 50 beats per minute with symptom resolution) predicts vagally mediated or AV nodal block that may not require temporary pacing 4 / Promising . Partial or absent atropine response, or block from infranodal causes, predicts the need for pacing and should accelerate the setup process rather than encouraging repeated atropine doses.

The Patient Experience

The man from Rantoul is back on the general cardiology floor by 6 AM. The pacing catheter exits from the right side of his neck, taped securely to his skin, coiling once before connecting to the beige Medtronic external pulse generator clipped to his gown. He is told not to turn his head sharply to the left, not to reach overhead with his right arm, and not to pull on anything connected to the device at his neck. His wife is in the room, watching the telemetry monitor on the wall, and she needs to be told that every wide-complex beat she sees is normal, that the spike she sees before each QRS is the pacemaker doing exactly what it is supposed to do.

For most patients, temporary transvenous pacing is not painful once placed. It is the transcutaneous pacing that precedes it that is remembered. Patients who have experienced both almost universally describe the transcutaneous pads as far more uncomfortable than the transvenous catheter itself, which, once positioned in the right ventricle, produces only a subtle awareness that something is different about the heartbeat.

Mobility is restricted. Bathroom privileges require nursing accompaniment. The catheter site must stay dry. The external generator alarm will sound if the lead displaces or if the battery runs low, and patients find the alarms disorienting, particularly at night.

The anxiety of waiting is real. The patient knows the external device is the only thing keeping his heart rate from falling to 28 beats per minute again. The cardiologist’s job is to explain clearly what the plan is: if the block does not resolve after revascularization, a permanent pacemaker will be placed, and that is a well-tolerated outpatient-equivalent procedure in most cases. Uncertainty in the short term does not mean uncertainty in the long term.

6.1 Sex Differences

Women who undergo temporary transvenous pacing for complete heart block are more likely to have conduction system disease from non-ischemic causes (Lev-Lenegre degenerative disease, sarcoidosis, autoimmune AV block, including anti-Ro/SSA antibody-associated conduction disease in women with connective tissue disorders) than men 4 / Promising . The presentation may be more insidious, with a longer history of dizziness, near-syncope, and fatigue before a presentation dramatic enough to prompt temporary pacing. Access site selection may require adjustment for body habitus.

Decisions and Trade-Offs

7.1 Bedside vs. Fluoroscopy-Guided Placement

The core decision at initiation is whether the patient is stable enough for fluoroscopy-guided placement. The hemodynamically unstable patient cannot wait; bedside balloon flotation with continuous ECG guidance must proceed immediately. The stable patient, or the patient who is adequately supported by transcutaneous pacing, benefits from fluoroscopic guidance, which increases first-attempt success, reduces lead displacement rates, and allows visualization of any perforation complication.

7.2 Femoral vs. Internal Jugular Access

Femoral access is faster, avoids pneumothorax risk entirely, and requires no neck positioning, which is advantageous in the post-resuscitation patient. The costs are higher infection risk after 72 hours and increased displacement risk with ambulation. Internal jugular access provides superior catheter stability for extended use but requires neck positioning that can be difficult in the obtunded or agitated patient.

7.3 When to Commit to Permanent Pacing

The decision to convert from temporary to permanent pacing requires a frank assessment of reversibility. Causes that are likely to resolve (inferior MI block, drug toxicity after drug clearance, Lyme carditis after antibiotic treatment, post-cardiac surgery block within 7 days) warrant waiting. Causes that are structural (complete heart block from degenerative conduction disease, anterior MI with persistent infranodal block) warrant early transition to permanent pacing, because prolonged temporary pacing increases infection risk without therapeutic benefit compared to proceeding to implantation.

Current ACC/AHA guidelines recommend permanent pacemaker implantation for persistent high-degree AV block after the reversible cause has been excluded or treated 5 / Solid .

7.4 Cost and Access

Temporary transvenous pacing is a hospital-based procedure. The equipment (introducer sheath, balloon pacing catheter, external pulse generator, telemetry monitoring) is available at every tertiary hospital and most community hospitals, but the procedural expertise required to place the catheter safely varies widely. In rural central Illinois and other underserved areas, the gap is not equipment but personnel: the cardiologist who is experienced enough to do this procedure at 2 AM reliably may not be available at the 25-bed critical access hospital.

Patients presenting to rural emergency departments with hemodynamically significant complete heart block should receive transcutaneous pacing immediately, atropine if appropriate, and transport to the nearest facility with interventional cardiology available. At Carle Foundation Hospital in Urbana, this capability is available 24/7. For patients in more remote areas, transfer arrangements should be established in advance of the emergency, not during it.

Clinical Synthesis

Temporary transvenous pacing sits at the far end of the care continuum: it is not a preventive intervention, and it is not a condition most people think about until the night arrives when they need it. The man from Rantoul did not know his AV node was failing. He was not on a cardiac monitoring program. He had no cardiologist. He drove himself to the hospital because the alternative was to stay in the driveway.

This clinical framework addresses this failure mode in two ways. First, through proactive cardiovascular assessment: a structured ECG review that can identify first-degree and second-degree AV block, bundle branch block patterns, and other conduction system findings that predict progression to symptomatic heart block, often years before the event. Second, through patient engagement: the educated patient who understands their conduction system abnormality will seek follow-up when symptoms emerge rather than attributing dizziness to dehydration and near-syncope to standing up too fast.

The temporary transvenous pacemaker is, in the end, a testimony to how far the art of resuscitation has come. A 72-year-old man with a pulse of 29 and a blood pressure of 78/54 who walked into an emergency department in 1960 had no intervention available. The same man in 2026 is on the telemetry floor by 6 AM, waiting for a discussion with his cardiologist about whether the block will resolve, and if it does not, when his permanent pacemaker can be scheduled.

That trajectory is what evidence-based procedural cardiology makes possible. The clinical mission of this site is to make sure the man from Rantoul is already connected to a cardiologist before that night arrives, so that the decision to pace is made electively, not at 2 AM in an emergency department with a borderline blood pressure.

Patients who want to understand their conduction system findings, their bundle branch block or first-degree AV block on a routine ECG, or their risk of developing high-degree AV block are appropriate candidates for a structured cardiovascular assessment. The assessment includes a structured ECG review, a symptom review, and a risk discussion that places the conduction finding in the context of the overall cardiac risk profile.

Appendix: Extended Clinical Notes: Temporary Transvenous Pacing

A.1 Specific Causes of Complete Heart Block: What the Cardiologist Considers

The etiology of complete heart block determines the expected duration of temporary pacing, the likelihood of spontaneous recovery, and the probability of requiring permanent pacing. A systematic approach by etiology:

Ischemic AV Block: Inferior MI accounts for the majority of acute complete heart block presentations in the cath lab and CCU setting. The right coronary artery supplies the AV node in approximately 90% of patients; its occlusion produces an AV nodal block characterized by a narrow QRS junctional escape rhythm at 40 to 60 beats per minute. The block is usually at the level of the AV node itself, often reversible within 3 to 7 days after successful revascularization 5 / Solid 90143-7). A temporary transvenous pacemaker is appropriate as a bridge.

Anterior MI with bilateral bundle branch block (RBBB + LAFB, RBBB + LPFB, or complete LBBB) represents an infranodal block that is far less likely to resolve. These patients require permanent pacing in the majority of cases. The temporary transvenous pacemaker is a bridge to permanent implantation rather than a bridge to recovery.

Drug-Induced AV Block: Beta-blocker or calcium channel blocker toxicity (the most common pharmacologic cause of complete heart block in an outpatient presentation) typically resolves as the drug is cleared. Supportive care, IV calcium gluconate (for calcium channel blocker toxicity, to increase inotropy and AV nodal conduction velocity), and high-dose insulin-euglycemia therapy (for refractory toxicity) are adjuncts. Temporary pacing may be required for hours to days while these interventions take effect.

Digoxin toxicity causes AV block through enhanced vagal tone and direct AV nodal suppression. At toxic concentrations, digoxin can produce any degree of AV block. Digoxin-specific antibody fragments (Digibind, DigiFab) can reverse digoxin toxicity within 30 to 60 minutes; temporary pacing bridges the interval until antidote effect is achieved.

Amiodarone and other class III antiarrhythmics can produce profound bradycardia and AV block, particularly in patients with pre-existing conduction system disease. The long half-life of amiodarone (40 to 55 days) means that stopping the drug does not produce rapid resolution; temporary pacing may be required for days.

Inflammatory and Infiltrative AV Block: Lyme disease myocarditis produces AV block in 0.4% of Lyme disease cases, typically in younger patients (mean age 30 to 40) with recent tick exposure in endemic regions. The block resolves with appropriate antibiotic therapy (doxycycline or amoxicillin) in essentially all cases, typically within 1 to 2 weeks 5 / Solid . Temporary transvenous pacing is a bridge to antibiotic-mediated recovery. Permanent pacing is rarely required. The clinical importance of recognizing Lyme carditis as a cause of complete heart block in a young patient in an endemic region (including Illinois, where Lyme disease is present in northern counties) cannot be overstated: this is a fully reversible condition with targeted antibiotic therapy.

Cardiac sarcoidosis can produce high-degree AV block from granulomatous infiltration of the interventricular septum and conduction system. Unlike Lyme disease, the block from sarcoidosis is less reliably reversible and more frequently requires permanent pacing 4 / Promising . The distinction from idiopathic conduction system disease requires an advanced workup: PET-CT for metabolically active sarcoid foci, cardiac MRI with late gadolinium enhancement, and often endomyocardial biopsy.

Anti-Ro/SSA antibody-associated complete congenital heart block, occurring in neonates of mothers with Sjogren’s syndrome or systemic lupus erythematosus, is a distinct entity not discussed here but relevant to obstetric cardiology consultants.

Post-Cardiac Surgery AV Block: Aortic valve replacement for calcific aortic stenosis carries a 3 to 5% risk of complete heart block requiring permanent pacing, from intraoperative injury to the bundle of His or the AV node during valve debridement or suture placement. Transcatheter aortic valve replacement (TAVR) carries a 15 to 30% rate of new left bundle branch block and a 5 to 12% rate of complete heart block requiring permanent pacing 5 / Solid . After cardiac surgery, a temporary transvenous pacemaker placed through the surgical field in the cardiac surgery ICU bridges the patient during the observation period while monitoring for spontaneous AV conduction recovery over 5 to 10 days.

A.2 Central Line Interactions During Temporary Transvenous Pacing

Patients in the CCU who have a temporary transvenous pacemaker placed through the right internal jugular or right subclavian vein often also require central venous access for medication infusion. The presence of a temporary pacing catheter through the same vein makes subsequent central line placement technically challenging and potentially dangerous.

Best practice: if both temporary pacing and central venous access are needed simultaneously, access the opposite side of the neck or use the femoral vein for central access. If both accesses must be on the same side (e.g., bilateral femoral access is contraindicated), use a dual-port or introducer sheath that accommodates both a pacing catheter and a central infusion port.

The right internal jugular approach for temporary pacing preserves the left subclavian vein for later permanent pacemaker implantation (which typically uses the left subclavian or axillary vein). This consideration should be explicit when selecting the temporary pacing access site in a patient likely to proceed to permanent pacing.

A.3 Pacing Thresholds: What Normal and Abnormal Look Like

Understanding pacing threshold behavior during a temporary transvenous pacing course allows clinicians to identify problems early:

Normal threshold evolution: after initial catheter placement, the pacing threshold is usually 0.5 to 1.5 milliamperes. Over the first 24 to 72 hours, the threshold typically rises as inflammatory edema develops at the electrode-endocardium interface (the acute phase response to foreign body contact). By day 3 to 5, thresholds stabilize at a new steady state, typically 1.5 to 3.0 milliamperes. Daily threshold checks at this level allow the set output to be appropriately adjusted to maintain the 2 to 3 times threshold safety margin.

Threshold elevation beyond normal: a sudden threshold elevation (from 2 milliamperes to 8 milliamperes overnight) suggests lead displacement or electrode migration. The clinical presentation is failure to capture. Check the fluoroscopic position of the catheter (or bedside chest X-ray), reposition if displaced, and recheck threshold before returning the patient to monitored care.

Very high threshold failure to capture: if maximal output (typically 10 to 20 milliamperes for temporary external pulse generators) fails to capture, and the lead position is confirmed to be at the RV apex, consider: severe hyperkalemia (potassium above 7.5 mEq/L can prevent myocardial depolarization by any level of external stimulation), severe hypoxia, severe acidosis, or cardiac tamponade (which can reduce cardiac output to the point that the right ventricle is compressed against the pericardium and the catheter cannot maintain contact with the endocardium).

A.4 Telemetry Monitoring During Temporary Transvenous Pacing

All patients with temporary transvenous pacemakers require continuous cardiac telemetry. The monitoring team must be able to distinguish:

• Normal paced rhythm: pacing spike followed by wide QRS complex in a regular pattern
• Sensing-based inhibition (demand mode): normal sinus or junctional beats suppressed the pacemaker output; no spikes visible when the native rate exceeds the set rate
• Failure to capture: pacing spikes not followed by QRS complexes
• Failure to sense: pacing spikes occurring despite native QRS complexes, particularly during the T wave (vulnerable period)

Nurses and monitor watchers who are not trained to recognize these patterns will call unnecessarily for “no pacemaker” (sensing inhibition in a patient with partial AV recovery) or miss failure to capture during non-paced intervals. Pre-pacing education for the nursing team is a patient safety requirement.

The monitor should be set to alert for heart rates below the programmed rate by 10 beats per minute (allowing for brief sensing inhibition) and for heart rates above a defined threshold (runaway pacemaker, an extremely rare emergency in modern devices).

A.5 Transition Planning: The 72-Hour Window

The 72-hour infection risk inflection point for temporary transvenous pacing creates a clinical decision that is sometimes deferred to the point of urgency rather than addressed prospectively. The attending cardiologist should have an explicit plan before the 72-hour mark:

Option 1: Remove the temporary pacemaker: appropriate if the underlying cause has resolved (AV block from inferior MI recovering to first-degree block on day 3, drug-cleared drug toxicity, immediate post-TAVR block that has recovered to sinus rhythm)

Option 2: Proceed to permanent pacemaker implantation: appropriate if the block has not resolved and is unlikely to resolve, and if the patient’s condition allows for a permanent implantation procedure (no active systemic infection, hemodynamically stable)

Option 3: Continue temporary pacing under enhanced infection precautions with a specific timeline: appropriate if the patient is not yet stable for permanent implantation but the underlying cause is expected to resolve (e.g., post-cardiac surgery block on day 4 that the surgeon believes may recover over the next week; Lyme carditis that was diagnosed on day 2 and antibiotic therapy was just started)

Option 3 should not default into indefinite extension. A specific date for reassessment should be documented in the plan, and if that date arrives without resolution, the question of permanent pacing must be explicitly revisited.

Clinical Synthesis: What Temporary Pacing Means in Practice

Temporary transvenous pacing sits at the intersection of acute rescue and durable prevention. The patient who arrives at Carle Foundation Hospital in complete heart block after an inferior MI has, in that moment, escaped a bradycardic arrest by margin of seconds. The pacer wire buys time, the catheterization laboratory restores the vessel, and 95% of those patients recover conduction within 7 days. But the same patient who required emergency pacing after an inferior MI now carries a heightened cardiovascular risk profile: completed myocardial infarction, likely underlying coronary artery disease, and demonstrated conduction system vulnerability 5 / Solid .

The thesis is that the emergency rescue event is the clinical moment to initiate the long-term risk reduction conversation. A patient who survives a paced inferior MI and receives only a discharge prescription without enrollment in a systematic secondary prevention and monitoring program has been rescued at the acute level and abandoned at the chronic level. A structured post-care program is designed for exactly this post-event patient: structured 90-day remote monitoring via Zio patch, pharmacist-directed beta-blocker and ACE inhibitor titration, and a scheduled 90-day electrophysiology evaluation to assess residual conduction system disease. The pacer wire is the beginning of the clinical relationship, not the end.

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.